Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management

Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management

The combination of glucagon-like peptide-1 (GLP-1) with other gut hormones including the glucose-dependent insulinotropic polypeptide (GIP) has been explored to complement and enhance further the GLP-1 effects on glycemia and weight loss. Tirzepatide is the first dual GLP-1/GIP receptor co-agonist w...

Full description

Bibliographic Details
Main Authors: Rachel Sinha, Dimitris Papamargaritis, Jack A. Sargeant, Melanie J. Davies
Format: Article
Language:English
Published: Korean Society for the Study of Obesity 2023-03-01
Series:Journal of Obesity & Metabolic Syndrome
Subjects:
diabetes mellitus
type 2
obesity
tirzepatide
glucagon-like peptide 1
gastric inhibitory polypeptide
Online Access:http://www.jomes.org/journal/view.html?doi=10.7570/jomes22067

Internet

http://www.jomes.org/journal/view.html?doi=10.7570/jomes22067

Similar Items